Abstract
Keloid is a complex condition with environmental and genetic risk-contributing factors. Two candidate genes, TGFβ1 and SMAD4, located in the same signaling pathway are highly expressed in the keloid fibroblast cells. In a case–control design, TGFβ1 haplotypes showed association with the risk of keloid in the present study. The CC haplotype, composed of both c.29C>T and −509T>C variants, was observed more frequently among cases (Corrected p = 0.037, OR = 2.07, 95 % CI = 0.87–4.93), showing a 4.5-fold increased risk for keloid. The AG genotype of the SMAD4 c.5131A>G variant showed a trend of significance (p = 0.0573, OR = 1.75, 95 % CI = 0.99–3.13). Taken together, either of these variants is most probably causative at the expression level or is in linkage disequilibrium with other causative variants in a complex pattern together with the environmental factors that contribute to the condition. To the best of our knowledge, there is only one documented report on a relationship between TGFβ1 and keloid with no association within the Caucasian population, while there have not been any reports for SMAD4. Therefore, the present study is likely the first research showing a significant association between TGFβ1 variants and keloids in the Malay population.
Similar content being viewed by others
References
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW (2002) Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 55:283–286
Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW (2003) Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 111(2):535–543
Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW (2004) Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 13:120–124
Becker T, Cichon S, Jonson E, Knapp M (2005) Multiple testing in the context of haplotype analysis revisited: application to case–control data. Ann Hum Genet 69:747–756
Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H (2009) Keloids: current concepts of pathogenesis (review). Int J Mol Med 24:283–293
Brown JJ, Ollier W, Arscott G, Ke X, Lamb J, Day P, Bayat A (2008) Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol 17:610–613
Brown JJ, Ollier WE, Thomson W, Bayat A (2008) Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 35:303–307
Flanders KC (2004) Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85:47–64
Gjessing HK, Lie RT (2006) Case-parent triads: estimating single- and double-dose effects of fetal and maternal disease gene haplotypes. Ann Hum Genet 70:382–396
Kelly AP (2004) Medical and surgical therapies for keloids. Dermatol Ther 17:212–218
Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT (1999) Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43:179–184
Li J, Cao J, Li M, Yu Y, Yang Y, Xiao X, Wu Z, Wang L, Tu Y, Chen H (2011) Collagen triple helix repeat containing-1 inhibits transforming growth factor-b1-induced collagen type I expression in keloid. Br J Dermatol 164:1030–1036
Liu Y, Gao J, Liu X, Lu F, Liu H (2008) Correlation analysis between clinical phenotypes of keloids and polymorphism of p53 gene codon 72. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22:1433–1436
Marneros AG, Norris JE, Olsen BR, Reichenberger E (2001) Clinical genetics of familial keloids. Arch Dermatol 137:1429–1434
Marneros AG, Norris JE, Watanabe S, Reichenberger E, Olsen BR (2004) Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 122:1126–1132
Nassiri M, Woolery-Lloyd H, Ramos S, Jacob SE, Gugic D, Viciana A, Romanelli P, Elgart G, Berman B, Vincek V (2009) Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloid-prone patients. Arch Dermatol Res 301:183–188
Niessen FB, Spauwen PH, Schalkwijk J, Kon M (1999) On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104:1435–1458
Oluwasanmi JO (1974) Keloids in the African. Clin Plast Surg 1:179–195
Omo-Dare P (1975) Genetic studies on keloid. J Natl Med Assoc 67:428–432
Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, Timpl R, Chu ML, Uitto J (1991) Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 97:240–248
Ridout CK, Keighley P, Krywawych S, Brown RM, Brown GK (2008) A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons. Hum Mutat 29:451
Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365–386
Segrè AV, Groop L, Mootha VK, Daly MJ, Altshuler D, DIAGRAM Consortium, MAGIC investigators (2010) Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet 6(8):Pii:e1001058
Shaffer JJ, Taylor SC, Cook-Bolden F (2002) Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 46:S63–S97
Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302:319–339
Vincze T, Posfai J, Roberts RJ (2003) NEBcutter: a program to cleave DNA with restriction enzymes. Nucleic Acids Res 31:3688–3691
Yan X, Gao JH, Chen Y, Song M, Liu XJ (2007) Preliminary linkage analysis and mapping of keloid susceptibility locus in a Chinese pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 23:32–35
Zuffardi O, Fraccaro M (1982) Gene mapping and serendipity. The locus for torticollis, keloids, cryptorchidism and renal dysplasia (31430, Mckusick) is at Xq28, distal to the G6PD locus. Hum Genet 62:280–281
Acknowledgments
We are grateful to the patients and their family members for their willing cooperation and participation in this study and to the members of the Human Genome Center and Reconstructive Sciences Unit for their help. This study was supported by a USM short-term grant (No. 304/PPSP/61310017).
Conflict of interest
The authors state no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Emami, A., Halim, A.S., Salahshourifar, I. et al. Association of TGFβ1 and SMAD4 variants in the etiology of keloid scar in the Malay population. Arch Dermatol Res 304, 541–547 (2012). https://doi.org/10.1007/s00403-012-1262-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-012-1262-0